Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Surprise synechia: a case of evolving chorionicity and fetal head entrapment by synechia diagnosed on prenatal ultrasound.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026

Same author

Design of a new Compton-TDCR spectrometer at Sofia University for the characterization of Liquid Scintillation cocktails.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025

Same author

Compact remanence-free permanent magnet-based variable magnetic field source.

The Review of scientific instruments·2024

Same author

Comminuted intraarticular calcaneal fractures: Multiplanar VA locked plating and interlocked nailing incorporate longitudinal strut and provide superior stability - a biomechanical cadaveric study.

Injury·2022

Same author

Using deep learning to detect digitally encoded DNA trigger for Trojan malware in Bio-Cyber attacks.

Scientific reports·2022

Same author

THE INFLUENCE OF FINISHING PROCESSING FEATURES ON THE POLYMERIZED COMPOSITE SURFACE STRUCTURE.

Georgian medical news·2022

Search research articles

Related Experiment Video

Updated: May 22, 2026

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

[Pregnancy and oncological diseases].

S Ivanov

Akusherstvo I Ginekologiia

|May 29, 2012

Summary

Cancer in pregnancy is rare but increasing. Treatment options like surgery and chemotherapy are safe after the first trimester, balancing maternal health with fetal development.

Area of Science:

Obstetrics and Gynecology
Gynecologic Oncology
Maternal-Fetal Medicine

Context:

Oncological diseases during pregnancy present unique challenges due to risks to the fetus from diagnostic procedures and treatments.
The incidence of cancer in pregnancy is rising, necessitating careful management strategies.

Purpose:

To assess and research domestic and international experiences in diagnosing and treating oncological diseases during pregnancy.
To evaluate the safety and efficacy of various treatment modalities in pregnant patients.

Summary:

A retrospective study analyzed 180 patients with gynecologic cancers (vulva, cervix, ovary, breast) and pregnancy over 10 years.
Treatment decisions for cervical cancer depend on stage, gestational age, and patient preference, with options including conservative management, radical hysterectomy, and chemo-radiotherapy.

Related Experiment Videos

Last Updated: May 22, 2026

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

Surgical intervention for adnexal masses is recommended in the second trimester, while chemotherapy for early-stage ovarian cancers may be deferred post-delivery.

Impact:

Oncological treatments, including surgery, chemotherapy, and radiotherapy (excluding pelvic/abdominal), can be safely administered after the first trimester of pregnancy.
The study offers two treatment algorithms for precancer and cancer of the uterine cervix and other gynecologic cancers in pregnancy.
Timely treatment of pregnant patients with oncological diseases is crucial, emphasizing a balance between maternal care and fetal well-being.